drugset / Trial / NCT03204006

Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients.

NCT03204006 ↗

Completed 70 enrolled Assiut University
RandomizedParallel-groupTriple-blindPrevention

Summary

Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients.

Timeline

Start
2018-03-08
Primary completion
2020-03-08
Completion
2020-03-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous

Indications

No indication recorded.